Sinovac's unit files application for public use of its Covid-19 vaccine to Chinese regulator
The application has been accepted by National Medical Products Administration for processing, Sinovac Biotech said in a statement
A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Sinovac Biotech said on Wednesday its unit Sinovac Life Science has filed application for the public use of its Covid-19 vaccine to Chinese medical product regulator.
The application has been accepted by National Medical Products Administration for processing, Sinovac Biotech said in a statement.
Keep updated, follow The Business Standard's Google news channel
